FLUDARABINE PHOSPHATE AND TOTAL-BODY IRRADIATION FOLLOWED BY DONOR PERIPHERAL BLOOD STEM CELL TRANSPLANT IN TREATING PATIENTS WITH ACUTE LYMPHOBLASTIC LEUKEMIA OR CHRONIC MYELOGENOUS LEUKEMIA THAT HAS RESPONDED TO TREATMENT WITH IMATINIB MESYLATE, DASATINIB, OR NILOTINIB: